EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cavity-Guided Chemiluminescent Probes for Drug-Metabolizing Enzymes: Rational Design , Activity Imaging, and Translational Applications

Zhuoan Jin, Xiaodong Li, Jing Zhang, Ling Yang

Biosensors · 10.11.2026 · 16 (11) · 642

DOI: 10.3390/bios16110642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, online erschienen am 10.11.2026. Verfasst von Zhuoan Jin und 3 weiteren Autor:innen. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-metabolizing enzymes (DMEs), which are crucial for xenobiotic biotransformation, profoundly influence therapeutic efficacy, drug safety, and physiological homeostasis. However, conventional analytical methods such as LC-MS/MS and fluorescence-based assays face limitations in background interference, spatiotemporal resolution, and in vivo imaging, while the structurally diverse catalytic cavities and overlapping substrate preferences of DMEs complicate isoform-specific activity assessment. In this context, chemiluminescence (CL) probes, particularly programmable Schaap-type 1,2-dioxetanes that operate without external light excitation, offer near-zero background and high sensitivity for monitoring DME activity. Here, cavity-guided CL probes are defined as probes whose recognition triggers, steric dimensions, electronic properties, and linker architectures are selected or optimized according to the substrate-binding and catalytic features of a target enzyme’s catalytic cavity. This review summarizes reported DME-targeted CL probes and discusses how active-pocket architecture and substrate-recognition rules can guide probe design for oxidases, hydrolases, and reductases. Representative applications in drug-metabolism analysis, drug–drug interaction assessment, disease-related activity imaging, and translational studies are highlighted. On this basis, we propose a design framework that matches active-pocket properties, substrate archetypes, and CL triggering mechanisms. A cross-case comparison now summarizes detection limits, linear ranges, emission wavelengths, signal enhancement, response characteristics, selectivity, precision, or reproducibility where reported, and biological applications; unreported parameters are explicitly identified as evidence gaps.

Zitieren

APA

Jin, Z., Li, X., Zhang, J., & Yang, L. (2026). Cavity-Guided Chemiluminescent Probes for Drug-Metabolizing Enzymes: Rational Design , Activity Imaging, and Translational Applications. Biosensors, 16(11), 642. https://doi.org/10.3390/bios16110642

Vancouver

Jin Z, Li X, Zhang J, Yang L. Cavity-Guided Chemiluminescent Probes for Drug-Metabolizing Enzymes: Rational Design , Activity Imaging, and Translational Applications. Biosensors. 2026;16(11):642. doi:10.3390/bios16110642

BibTeX
@article{Jin2026,
  author = {Jin, Zhuoan and Li, Xiaodong and Zhang, Jing and Yang, Ling},
  title = {Cavity-Guided Chemiluminescent Probes for Drug-Metabolizing Enzymes: Rational Design , Activity Imaging, and Translational Applications},
  journal = {Biosensors},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {642},
  doi = {10.3390/bios16110642}
}
Kostenlos starten →